Variant report

Variant	esv3357134
Chromosome Location	chr9:116925431-116930729
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:83)
CpG islands
(count:123)
Chromatin interactive
region (count:2)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:83 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr9:116925776-116926107	HepG2	liver:	n/a	n/a
2	CHD2	chr9:116925741-116926067	H1-hESC	embryonic stem cell:	n/a	n/a
3	CHD2	chr9:116925792-116926044	HepG2	liver:	n/a	n/a
4	CTCF	chr9:116925720-116925870	HBMEC	blood vessel:	n/a	n/a
5	CTCF	chr9:116929720-116929870	Hela-S3	cervix:	n/a	chr9:116929816-116929826 chr9:116929811-116929829
6	CTCF	chr9:116929820-116929970	HBMEC	blood vessel:	n/a	n/a
7	CTCF	chr9:116929560-116929710	AG10803	skin:	n/a	n/a
8	E2F6	chr9:116925614-116926216	H1-hESC	embryonic stem cell:	n/a	chr9:116926139-116926148
9	EP300	chr9:116925715-116926118	HepG2	liver:	n/a	n/a
10	EP300	chr9:116925758-116926134	HepG2	liver:	n/a	n/a
11	FOS	chr9:116928817-116929328	HUVEC	blood vessel:	n/a	chr9:116928899-116928910
12	FOS	chr9:116926503-116926778	MCF10A-Er-Src	breast:	n/a	chr9:116926639-116926651 chr9:116926641-116926649
13	FOS	chr9:116926587-116926677	MCF10A-Er-Src	breast:	n/a	chr9:116926639-116926651 chr9:116926641-116926649
14	FOS	chr9:116926560-116926777	MCF10A-Er-Src	breast:	n/a	chr9:116926639-116926651 chr9:116926641-116926649
15	FOS	chr9:116926480-116926777	MCF10A-Er-Src	breast:	n/a	chr9:116926639-116926651 chr9:116926641-116926649
16	FOSL2	chr9:116925741-116926263	HepG2	liver:	n/a	chr9:116926138-116926147
17	FOSL2	chr9:116926489-116926808	HepG2	liver:	n/a	chr9:116926639-116926651 chr9:116926641-116926649
18	GABPA	chr9:116925777-116926108	H1-hESC	embryonic stem cell:	n/a	n/a
19	GATA2	chr9:116928987-116929399	HUVEC	blood vessel:	n/a	n/a
20	GATA2	chr9:116929627-116929840	SH-SY5Y	brain:	n/a	chr9:116929759-116929768 chr9:116929758-116929770 chr9:116929761-116929768
21	GATA3	chr9:116929591-116929791	SH-SY5Y	brain:	n/a	chr9:116929759-116929768 chr9:116929758-116929770 chr9:116929761-116929768
22	HNF4A	chr9:116925799-116926192	HepG2	liver:	n/a	chr9:116925964-116925986
23	IRF1	chr9:116929555-116929670	K562	blood:	n/a	n/a
24	JUND	chr9:116925858-116925976	H1-hESC	embryonic stem cell:	n/a	n/a
25	MAFK	chr9:116926038-116926093	HepG2	liver:	n/a	n/a
26	MAFK	chr9:116925935-116926243	IMR90	lung:	n/a	chr9:116926117-116926127
27	MAX	chr9:116925700-116926114	H1-hESC	embryonic stem cell:	n/a	n/a
28	MAX	chr9:116925739-116926008	H1-hESC	embryonic stem cell:	n/a	n/a
29	MAX	chr9:116925695-116926170	HepG2	liver:	n/a	n/a
30	MAX	chr9:116925691-116926148	ECC-1	luminal epithelium:	n/a	n/a
31	MAX	chr9:116925619-116926177	A549	lung:	n/a	n/a
32	MAX	chr9:116925651-116926215	HepG2	liver:	n/a	n/a
33	MAX	chr9:116925775-116926035	HepG2	liver:	n/a	n/a
34	MAX	chr9:116925673-116926152	H1-hESC	embryonic stem cell:	n/a	n/a
35	MAX	chr9:116925747-116926135	A549	lung:	n/a	n/a
36	MAZ	chr9:116925836-116926113	HepG2	liver:	n/a	n/a
37	MAZ	chr9:116925543-116926838	IMR90	lung:	n/a	n/a
38	MXI1	chr9:116925748-116926074	H1-hESC	embryonic stem cell:	n/a	n/a
39	MXI1	chr9:116925751-116926104	HepG2	liver:	n/a	n/a
40	MXI1	chr9:116925553-116926681	IMR90	lung:	n/a	n/a
41	MYBL2	chr9:116925762-116926183	HepG2	liver:	n/a	n/a
42	MYC	chr9:116925800-116925997	HepG2	liver:	n/a	n/a
43	MYC	chr9:116925735-116926003	MCF10A-Er-Src	breast:	n/a	n/a
44	MYC	chr9:116925908-116925990	MCF-7	breast:	n/a	n/a
45	POLR2A	chr9:116929645-116930382	HepG2	liver:	n/a	n/a
46	POLR2A	chr9:116928192-116928555	HepG2	liver:	n/a	n/a
47	POLR2A	chr9:116925846-116925860	HepG2	liver:	n/a	n/a
48	POLR2A	chr9:116928709-116928784	HepG2	liver:	n/a	n/a
49	POLR2A	chr9:116928575-116928596	HepG2	liver:	n/a	n/a
50	POLR2A	chr9:116925865-116925939	HepG2	liver:	n/a	n/a

(count:123 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:116929797-116929847	AG10803	skin:	n/a
2	chr9:116929797-116929847	AG10803	skin:	n/a
3	chr9:116930367-116930417	T-47D	breast:	n/a
4	chr9:116929797-116929847	GM12891	blood:	n/a
5	chr9:116930367-116930417	HEK293	kidney:	embryo
6	chr9:116929797-116929847	ECC-1	luminal epithelium:	n/a
7	chr9:116930367-116930417	AG10803	skin:	n/a
8	chr9:116929797-116929847	LNCaP	prostate:	n/a
9	chr9:116930367-116930417	NH-A	brain:	n/a
10	chr9:116929797-116929847	HPAEpiC	pulmonary alveolar:	n/a
11	chr9:116929797-116929847	ovcar-3	ovarian:	n/a
12	chr9:116930367-116930417	HIPEpiC	eye:	n/a
13	chr9:116929797-116929847	HEEpiC	esophagus:	n/a
14	chr9:116930367-116930417	Hepatocyte	liver:	n/a
15	chr9:116930367-116930417	A549	lung:	n/a
16	chr9:116930367-116930417	HAEpiC	amniotic membrane:	n/a
17	chr9:116929797-116929847	Caco-2	colon:	n/a
18	chr9:116929797-116929847	HAEpiC	amniotic membrane:	n/a
19	chr9:116929797-116929847	SK-N-MC	brain:	n/a
20	chr9:116929797-116929847	HCM	heart:	n/a
21	chr9:116929797-116929847	BE2_C	brain:	n/a
22	chr9:116929797-116929847	SKMC	muscle:	n/a
23	chr9:116930367-116930417	HMEC	breast:	n/a
24	chr9:116929797-116929847	SAEC	small airway:	n/a
25	chr9:116930367-116930417	CMK	blood:	n/a
26	chr9:116929797-116929847	HNPCEpiC	eye:	n/a
27	chr9:116930367-116930417	HNPCEpiC	eye:	n/a
28	chr9:116929797-116929847	HepG2	liver:	n/a
29	chr9:116930367-116930417	HRPEpiC	eye:	n/a
30	chr9:116930367-116930417	HCPEpiC	choroid plexus:	n/a
31	chr9:116930367-116930417	Jurkat	blood:	n/a
32	chr9:116929797-116929847	PANC-1	pancreas:	n/a
33	chr9:116930367-116930417	Hela-S3	cervix:	n/a
34	chr9:116930367-116930417	GM12878	blood:	n/a
35	chr9:116929797-116929847	NB4	blood:	n/a
36	chr9:116930367-116930417	SAEC	small airway:	n/a
37	chr9:116930367-116930417	IMR90	lung:	fetal
38	chr9:116929797-116929847	NHDF-neo	bronchial:	n/a
39	chr9:116930367-116930417	LNCaP	prostate:	n/a
40	chr9:116930367-116930417	NHDF-neo	bronchial:	n/a
41	chr9:116930367-116930417	GM12892	blood:	n/a
42	chr9:116929797-116929847	A549	lung:	n/a
43	chr9:116930367-116930417	ovcar-3	ovarian:	n/a
44	chr9:116929797-116929847	T-47D	breast:	n/a
45	chr9:116930367-116930417	AG09309	skin:	n/a
46	chr9:116929797-116929847	HRE	kidney:	n/a
47	chr9:116929797-116929847	MCF-7	breast:	n/a
48	chr9:116929797-116929847	IMR90	lung:	fetal
49	chr9:116930367-116930417	RPTEC	kidney:	n/a
50	chr9:116930367-116930417	HEEpiC	esophagus:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr9:116927426..116928989-chr9:116941833..116943417,2	K562	blood:
2	chr9:116870237..116871907-chr9:116924776..116927376,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KIF12-3	chr9:116929050-116929727	NONHSAT134369
2	lnc-KIF12-3	chr9:116929847-116930010	NONHSAT134369
3	lnc-KIF12-3	chr9:116928407-116928523	NONHSAT134369

No data

Variant related genes	Relation type
COL27A1	TF binding region
COL27A1	CpG island

Extended variants
information (count: 280 )
Associated
traits (count: 61 )

Variant overlapped rSNPs/rCNVs (count:280 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs533577437	chr9:116925451-116925452	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs553696521	chr9:116925470-116925471	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs577130234	chr9:116925506-116925507	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs55916825	chr9:116925513-116925514	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs546083998	chr9:116925539-116925540	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs562779786	chr9:116925554-116925555	Weak transcription Enhancers Flanking Active TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs145207937	chr9:116925560-116925561	Weak transcription Enhancers Flanking Active TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs145098091	chr9:116925589-116925590	Weak transcription Enhancers Flanking Active TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs562062375	chr9:116925635-116925636	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs574165168	chr9:116925644-116925645	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs34666325	chr9:116925684-116925685	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs148680672	chr9:116925739-116925740	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs541074895	chr9:116925753-116925754	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs564427982	chr9:116925782-116925783	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs532496780	chr9:116925789-116925790	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs552491979	chr9:116925798-116925799	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs569106956	chr9:116925802-116925803	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs2808797	chr9:116925810-116925811	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs142083582	chr9:116925875-116925876	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs568081178	chr9:116925876-116925877	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs547105408	chr9:116925906-116925907	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs566732622	chr9:116925907-116925908	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs553532935	chr9:116925924-116925925	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs570101384	chr9:116925952-116925953	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs539775087	chr9:116925959-116925960	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs556414779	chr9:116926025-116926026	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs553168576	chr9:116926089-116926090	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs192074941	chr9:116926120-116926121	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs555886915	chr9:116926137-116926138	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs572450548	chr9:116926150-116926151	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs151142419	chr9:116926161-116926162	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs564514031	chr9:116926175-116926176	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs140224892	chr9:116926233-116926234	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs546147465	chr9:116926245-116926246	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs73656004	chr9:116926255-116926256	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs531602755	chr9:116926262-116926263	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs145331992	chr9:116926267-116926268	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs1864724	chr9:116926271-116926272	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs184672509	chr9:116926304-116926305	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs547073247	chr9:116926310-116926311	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs4588934	chr9:116926311-116926312	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs35196615	chr9:116926390-116926391	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs73656005	chr9:116926480-116926481	Enhancers Weak transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs375439745	chr9:116926488-116926489	Enhancers Weak transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs555705395	chr9:116926530-116926531	Enhancers Weak transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs146443601	chr9:116926539-116926540	Enhancers Weak transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs1864723	chr9:116926649-116926650	Enhancers Weak transcription Genic enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs371607911	chr9:116926657-116926658	Enhancers Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs187578023	chr9:116926717-116926718	Enhancers Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs192620409	chr9:116926861-116926862	Weak transcription Enhancers Strong transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:61)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	18632612	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Gastric cancer	17908304	CNVD
small cell lung cancer	20016488	CNVD
Cardiac fibroma	18329553	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Lung cancer	19147751	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Melanoma	18172304	CNVD
Colorectal cancer	16272173	CNVD
Bladder cancer	21909424	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	21509527	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Cervical cancer	16585170	CNVD
Ependymoma	19289631	CNVD
Melanoma	17363583	CNVD

Chromatin state (count:332 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:116919000-116925800	Weak transcription	Gastric	stomach
2	chr9:116919000-116936600	Weak transcription	Brain Hippocampus Middle	brain
3	chr9:116919000-116937600	Weak transcription	Placenta Amnion	Placenta Amnion
4	chr9:116919200-116972000	Weak transcription	H9 Cell Line	embryonic stem cell
5	chr9:116919400-116925800	Weak transcription	Ovary	ovary
6	chr9:116919400-116930000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr9:116919600-116925600	Weak transcription	Fetal Heart	heart
8	chr9:116919600-116939600	Weak transcription	Hela-S3	cervix
9	chr9:116919800-116925600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
10	chr9:116919800-116925600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
11	chr9:116919800-116925600	Enhancers	Fetal Intestine Large	intestine
12	chr9:116919800-116925600	Weak transcription	Fetal Kidney	kidney
13	chr9:116919800-116925800	Weak transcription	Lung	lung
14	chr9:116919800-116927000	Enhancers	Liver	Liver
15	chr9:116919800-116927200	Genic enhancers	Fetal Intestine Small	intestine
16	chr9:116920400-116925600	Weak transcription	HMEC	breast
17	chr9:116920600-116925600	Weak transcription	Colon Smooth Muscle	Colon
18	chr9:116920600-116925600	Weak transcription	Right Ventricle	heart
19	chr9:116920800-116925600	Weak transcription	HUVEC	blood vessel
20	chr9:116920800-116925800	Weak transcription	Cortex derived primary cultured neurospheres	brain
21	chr9:116921800-116925600	Weak transcription	Rectal Smooth Muscle	rectum
22	chr9:116921800-116931600	Weak transcription	Aorta	Aorta
23	chr9:116922000-116925600	Weak transcription	A549	lung
24	chr9:116922200-116925600	Weak transcription	H1 Cell Line	embryonic stem cell
25	chr9:116922200-116925800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
26	chr9:116922200-116925800	Weak transcription	Rectal Mucosa Donor 31	rectum
27	chr9:116922400-116925600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
28	chr9:116922400-116925600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
29	chr9:116922400-116925600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
30	chr9:116922400-116925600	Weak transcription	Duodenum Mucosa	Duodenum
31	chr9:116922400-116925800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
32	chr9:116922400-116925800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
33	chr9:116923000-116925600	Enhancers	Skeletal Muscle Female	skeletal muscle
34	chr9:116923000-116926800	Enhancers	Skeletal Muscle Male	skeletal muscle
35	chr9:116923200-116927000	Genic enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
36	chr9:116923600-116925600	Enhancers	Fetal Muscle Trunk	muscle
37	chr9:116923600-116926400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
38	chr9:116923600-116926800	Enhancers	Psoas Muscle	Psoas
39	chr9:116924000-116926400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
40	chr9:116924000-116926400	Enhancers	Left Ventricle	heart
41	chr9:116924000-116926400	Enhancers	Stomach Mucosa	stomach
42	chr9:116924000-116926800	Genic enhancers	Fetal Stomach	stomach
43	chr9:116924000-116927000	Enhancers	Pancreas	Pancrea
44	chr9:116924200-116926800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr9:116924200-116927000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
46	chr9:116924200-116927000	Enhancers	Fetal Muscle Leg	muscle
47	chr9:116924400-116925600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
48	chr9:116924400-116925600	Genic enhancers	NHEK	skin
49	chr9:116924400-116926000	Enhancers	Esophagus	oesophagus
50	chr9:116924400-116926400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links